NCT00185289

Brief Summary

The purpose of this study is to evaluate the safety and effectiveness of a new 4-phasic preparation in the prevention of pregnancies in a large group of volunteers.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,392

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Apr 2004

Geographic Reach
3 countries

50 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2004

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

September 10, 2005

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 16, 2005

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2006

Completed
Last Updated

July 15, 2011

Status Verified

July 1, 2011

First QC Date

September 10, 2005

Last Update Submit

July 14, 2011

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of unintended pregnancies

    20 treatment cycles each consisting of 28 days and follow-up period of 14 days

Secondary Outcomes (1)

  • Adverse event collection

    20 treatment cycles each consisting of 28 days

Study Arms (1)

Arm 1

EXPERIMENTAL
Drug: EV/DNG (Qlaira, BAY86-5027, SH T00658K)

Interventions

per cycle (28 days): Days 1-2: 3.0 mg EV; Days 3-7: 2.0 mg EV + 2.0 mg DNG; Days 8-24: 2.0 mg EV + 3.0 mg DNG; Days 25-26: 1.0 mg EV; Days 27-28: Placebo

Arm 1

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy volunteers

You may not qualify if:

  • Any condition that might interfere the outcomes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (50)

Dr. Max Stiglbauer

Wiener Neustadt, Lower Austria, 2700, Austria

Location

Praxis Dr. Langer

Fürstenfeld, Styria, 8280, Austria

Location

Dr. Meusburger

Wolfurt, Vorarlberg, 6922, Austria

Location

Landeskrankenhaus Bregenz

Bregenz, 6900, Austria

Location

Dr. Roswitha Wessely

Graz, 8010, Austria

Location

Institut für Hormonstörungen und Kinderwunsch

Graz, 8010, Austria

Location

Praxis Dr. Gudrun Lorenz-Eberhard

Graz, 8010, Austria

Location

Praxis Dr. Hannes Kahr

Graz, 8010, Austria

Location

Universitätsklinikum Innsbruck

Innsbruck, 6020, Austria

Location

Dr. Peter Mayr

Kufstein, 6330, Austria

Location

Dr. Michaela Boeckl

Salzburg, 5020, Austria

Location

Dr. Sigrid Schmidl-Amann

Sankt Pölten, 3100, Austria

Location

Dr. Guenther Heytmanek

Vienna, 1030, Austria

Location

Dr. Ewald Boschitsch

Vienna, 1060, Austria

Location

Dr. Brigitte Wiesenthal

Vienna, 1070, Austria

Location

Allgemeines Krankenhaus der Stadt Wien Universitätskliniken

Vienna, 1090, Austria

Location

Dr. Wolfgang Bartl

Vienna, 1200, Austria

Location

Dr. Walter Paulik

Zeltweg, 8740, Austria

Location

Praxis Hr. Dr. A. Soder

Ettlingen, Baden-Wurttemberg, 76275, Germany

Location

Praxis Hr. Dr. U. Kohoutek

Karlsruhe, Baden-Wurttemberg, 76199, Germany

Location

Praxis Hr. Dr. L. Weihe

Ansbach, Bavaria, 91522, Germany

Location

Praxis Hr. Dr. D. Rautenberg

Hamburg, Hamburg, 21073, Germany

Location

Frauenarztpraxis Dr. med. Wolfram Brach

Dietzenbach, Hesse, 63128, Germany

Location

Praxis Hr. Dr. Werner Göttker-Schnetmann

Frankfurt am Main, Hesse, 60322, Germany

Location

Praxis Dr. S. El Tobgui-Jensen

Frankfurt am Main, Hesse, 60439, Germany

Location

Praxis Dr. S. Clauss-Hoffmann

Frankfurt am Main, Hesse, 65929, Germany

Location

Praxis Hr. Dr. P. Schwaner

Frankfurt am Main, Hesse, 65936, Germany

Location

Praxis Dr. Kindt

Langen, Hesse, 63225, Germany

Location

Praxis Fr. Dr. J. Tyagi

Mühlheim am Main, Hesse, 63165, Germany

Location

Praxis Hr. Dr. H. Zabel

Bovenden, Lower Saxony, 37120, Germany

Location

Praxis Hr. Dr. K. Brauns

Hamelin, Lower Saxony, 31785, Germany

Location

Praxis Hr. Dr. K. Greven

Hanover, Lower Saxony, 30459, Germany

Location

Praxis Hr. Dr. H. Frommeyer

Osnabrück, Lower Saxony, 49074, Germany

Location

Frauenarztpraxis Dr. Schoenberg

Rheine, North Rhine-Westphalia, 48431, Germany

Location

Praxis Fr. I. Gröger

Wurzen, Saxony, 04808, Germany

Location

Praxis Hr. H. Thelen

Jessen, Saxony-Anhalt, 06917, Germany

Location

Frauenarztpraxis Dr. med. Gabriele Weinreich

Magdeburg, Saxony-Anhalt, 39130, Germany

Location

Dinox GmbH Berlin

Berlin, State of Berlin, 10115, Germany

Location

Charité Campus Benjamin Franklin

Berlin, State of Berlin, 12200, Germany

Location

Frauenarztpraxis Fr. Dr. S. Gramatte

Berlin, State of Berlin, 12435, Germany

Location

Praxis Fr. Dr. B. Wernecke

Berlin, State of Berlin, 12435, Germany

Location

Praxis Fr. Dr. I. Hannig

Berlin, State of Berlin, 12435, Germany

Location

Praxis Fr. Dr. K. Maar

Berlin, State of Berlin, 13507, Germany

Location

Praxis Hr. Dr. R. Etzrodt

Gera, Thuringia, 07545, Germany

Location

Frauenarztpraxis Fr. Dr. H. Schlegel

Saalfeld, Thuringia, 07318, Germany

Location

USP Institut Universitari Dexeus

Barcelona, Barcelona, 08028, Spain

Location

Diatros Gava- Centre Assistencial Ntra. Sra. de Burgues

Gavà, Barcelona, 08850, Spain

Location

Hospital Universitario MAterno Infantil de Canarias

Las Palmas, Gran Canaria, 35016, Spain

Location

Instituto Palacios de Salud y Medicina de la Mujer

Madrid, 28009, Spain

Location

Complejo Hospitalario Ntra. Sra. de Valme

Seville, 41014, Spain

Location

Study Officials

  • Bayer Study Director

    Bayer

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

September 10, 2005

First Posted

September 16, 2005

Study Start

April 1, 2004

Study Completion

July 1, 2006

Last Updated

July 15, 2011

Record last verified: 2011-07

Locations